Short answer · Medically reviewed summary · Last updated: 2026-04-06
The ICD-10-CM code for Progressive Supranuclear Palsy (Steele-Richardson-Olszewski syndrome) is G23.1, while the corresponding ICD-9-CM code is 333.0. Understanding the Diagnostic Coding In clinical practice, accurate coding is essential for ensuring that patients with Progressive Supranuclear Palsy receive appropriate care and insurance coverage. The code G23.1 specifically categorizes this neurodegenerative condition under "Other specified diseases of basal ganglia." While these codes provide a standardized administrative language for medical billing and epidemiological tracking, they do not capture the profound complexity of living with Progressive Supranuclear Palsy.
3 people with Progressive Supranuclear Palsy have shared their first-person experience on this question at DiseaseMaps.
ICD10 code of Progressive Supranuclear Palsy and ICD9 code
ICD-10 and ICD-9 codes for Progressive Supranuclear Palsy, with classification details for clinicians, coders and patients.
The ICD-10-CM code for Progressive Supranuclear Palsy (Steele-Richardson-Olszewski syndrome) is G23.1, while the corresponding ICD-9-CM code is 333.0.
Understanding the Diagnostic Coding
In clinical practice, accurate coding is essential for ensuring that patients with Progressive Supranuclear Palsy receive appropriate care and insurance coverage. The code G23.1 specifically categorizes this neurodegenerative condition under "Other specified diseases of basal ganglia." While these codes provide a standardized administrative language for medical billing and epidemiological tracking, they do not capture the profound complexity of living with Progressive Supranuclear Palsy. As a physician, I recognize that a diagnosis code is merely a starting point; the real challenge lies in managing the constellation of symptoms, such as the hallmark vertical supranuclear gaze palsy and the significant postural instability that characterizes the condition.
Clinical Implications and Patient Support
Because Progressive Supranuclear Palsy is a progressive tauopathy, the clinical focus must shift over time from initial diagnostic confirmation to comprehensive symptom management. Beyond the coding, we prioritize multidisciplinary care that addresses the specific needs of the nervous system, including speech therapy for slurred speech (dysarthria) and swallowing difficulties (dysphagia). It is common for families to feel overwhelmed when these diagnostic codes are first introduced, but please remember that you are not just a code; you are a person with unique needs. The 808 members of our DiseaseMaps community often find that sharing strategies for managing daily balance and communication challenges is just as important as the clinical diagnosis of Progressive Supranuclear Palsy itself. Understanding the medical classification helps us advocate for targeted therapies and research, ensuring that those affected by Progressive Supranuclear Palsy are visible within the global healthcare system.
Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your neurologist or other qualified health provider with any questions you may have regarding your medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Progressive Supranuclear Palsy
- Orphanet: Progressive Supranuclear Palsy (ORPHA:790)
- CurePSP: Foundation for PSP and CBD
- Online Mendelian Inheritance in Man (OMIM): Progressive Supranuclear Palsy (Entry #601104)
Posted Aug 12, 2017 by Diana Sanders 2000
Posted Sep 24, 2021 by matina 2610
Posted Nov 8, 2017 by Maria Veronica Ortiz Solís 2000
